SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-026258
Filing Date
2019-07-26
Accepted
2019-07-26 09:15:36
Documents
14
Period of Report
2019-07-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20190726.htm   iXBRL 8-K 33722
2 PRESS RELEASE acor-ex991_35.htm EX-99.1 45552
3 GRAPHIC gchrqrmpeopc000001.jpg GRAPHIC 4800
  Complete submission text file 0001564590-19-026258.txt   213522

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20190726.xsd EX-101.SCH 6193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20190726_lab.xml EX-101.LAB 19069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20190726_pre.xml EX-101.PRE 11717
7 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20190726_htm.xml XML 3416
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 19976138
SIC: 2836 Biological Products, (No Diagnostic Substances)